TABLE 2.

Clinical, Imaging, and Histopathologic Patient Data

Patient no.	Age (y)	Sex	Tumor type	No. of lesions/sites
Patient no.	Age (y)	Sex	Tumor type	¹¹¹In-DTPA-OC	⁶⁴Cu-TETA-OC	Follow-up*
1	70	M	Carcinoid	6/SB and LN	6/SB and LN, adrenal glands	Multifocal/SB, 10/LN
2	45	M	Carcinoid	Innumerable/skin, stomach, pancreas, liver	Innumerable/skin, stomach, pancreas, liver, adrenal glands	Widespread disease
3	45	F	Carcinoid	1/LN, 3/bone, diffuse/liver	1/LN, 4/bone, LN, diffuse/liver	1/LN, diffuse/bone and liver
4	46	F	Islet cell NF pancreatic	No lesions	No lesions	No lesions
5	46	M	Islet cell MEN-I NF pancreatic	2/pancreas, 1/liver	2/pancreas, 1/liver	Multifocal/pancreas and spleen, 1/liver
6	58	M	Carcinoid	2/SB or LN	9/SB or LN, 2/bones	Multifocal/SB, 11/LN
7	61	M	Carcinoid	1/liver, 1/LN or SB	1/liver, 1/LN or SB, adrenal glands	1/liver, multiple/SB and LN
8	64	M	Islet cell NF pancreatic	1/lung, mild uptake	No lesions†	Numerous/liver, bone, pancreas, peritoneum

↵* Pathologic, radiologic, and clinical.
↵† This patient did not undergo late imaging.
SB = small bowel; LN = lymph nodes; NF = nonfunctioning; MEN-I = multiple endocrine neoplasia, type I.